Nilemdo 180 mg

Nilemdo 180 mg is a medicine authorised by Swissmedic under authorisation number 67583. The authorisation holder is Daiichi Sankyo (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 December 2020 and the authorisation is valid without a time limit. ATC code C10AX15 places the medicine in the group Lipid modifying agents.

Dispensing category B
Authorisation number 67583
ATC C10AX15
Synthetic medicines

Authorisation data
Authorisation number	67583
Name	Nilemdo 180 mg
Full name	Nilemdo 180 mg, Filmtabletten
Authorisation holder	Daiichi Sankyo (Schweiz) AG
Medicinal product code	Synthetic medicines
Dispensing category	B · Prescription only
ATC code	C10AX15
First authorisation	14 December 2020
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Nilemdo 180 mg, Filmtabletten	B	14 December 2020

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	28	mg	C10AX15	07.12.0.	B
2	98	mg	C10AX15	07.12.0.	B

Scroll the table sideways

Other medicines from this authorisation holder

DATROWAY 100 mgAuthorisation number 69801 · ATC L01FX35A Enhertu 100 mgAuthorisation number 67967 · ATC L01FD04A Lixiana 15 mgAuthorisation number 65149 · ATC B01AF03B Nustendi 180 mg / 10 mgAuthorisation number 67586 · ATC C10BA10B Olmetec 10 mgAuthorisation number 55907 · ATC C09CA08B Olmetec Plus 20/12Authorisation number 57038 · ATC C09DA08B Sevikar 20mg/5mgAuthorisation number 58778 · ATC C09DB02B Sevikar HCT 20 mg/5 mg/12.5 mgAuthorisation number 61519 · ATC C09DX03B

Frequently asked questions

Is Nilemdo 180 mg authorised in Switzerland?

Yes. Nilemdo 180 mg is authorised by Swissmedic under authorisation number 67583, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Nilemdo 180 mg have?

Nilemdo 180 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Nilemdo 180 mg?

The authorisation holder is Daiichi Sankyo (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.